Clinical Trials Browser

Interventional × ALT-801 × Plasma cell × Clear all

NCT01670994 2024-06-18

QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Terminated

6 enrolled 10 charts

Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Recurrence